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Abstract
Background: Tissue resident mesenchymal stem cells (MSCs) are multipotent, self-renewing cells known for their
differentiation potential into cells of mesenchymal lineage. The ability of single cell clones isolated from adipose
tissue resident MSCs (ASCs) to differentiate into cells of hematopoietic lineage has been previously demonstrated.
In the present study, we investigated if the hematopoietic differentiated (HD) cells derived from ASCs could
productively be infected with HIV-1.
Results: HD cells were generated by differentiating clonally expanded cultures of adherent subsets of ASCs (CD90
+,
CD105
+, CD45
-, and CD34
-). Transcriptome analysis revealed that HD cells acquire a number of elements that increase
their susceptibility for HIV-1 infection, including HIV-1 receptor/co-receptor and other key cellular cofactors. HIV-1
infected HD cells (HD-HIV) showed elevated p24 protein and gag and tat gene expression, implying a high and
productive infection. HD-HIV cells showed decreased CD4, but significant increase in the expression of CCR5, CXCR4,
Nef-associated factor HCK, and Vpu-associated factor BTRC. HIV-1 restricting factors like APOBEC3F and TRIM5 also
showed up regulation. HIV-1 infection increased apoptosis and cell cycle regulatory genes in HD cells. Although
undifferentiated ASCs failed to show productive infection, HIV-1 exposure increased the expression of several
hematopoietic lineage associated genes such as c-Kit, MMD2, and IL-10.
Conclusions: Considering the presence of profuse amounts of ASCs in different tissues, these findings suggest the
possible role that could be played by HD cells derived from ASCs in HIV-1 infection. The undifferentiated ASCs
were non-permissive to HIV-1 infection; however, HIV-1 exposure increased the expression of some hematopoietic
lineage related genes. The findings relate the importance of ASCs in HIV-1 research and facilitate the
understanding of the disease process and management strategies.
Background
Human immunodeficiency virus type 1 (HIV-1), the
etiologic agent of acquired immune deficiency syndrome
(AIDS), predominantly infects hematopoietic cells such
as T-helper lymphocytes, monocytes and macrophages.
Despite the development of highly active anti-retroviral
therapy (HAART), the persistence of reservoirs of
HIV-1 poses obstacles to the eradication of the disease.
Although initial viral decay kinetics in plasma had indi-
cated optimistic outcomes of HAART [1], long-term
measurements have suggested that mononuclear
lymphocytes harbor the virus for prolonged periods of
time [2].
Infection of lymphoid and myeloid lineages is
mediated by recognition of the T-cell receptor CD4 or
by the chemokine co-receptors CXCR4 and CCR5.
CXCR4 appears to be the most important for HIV-1
entry into T-lymphocytes (T-tropic), whereas CCR5 is
known for viral entry into cells such as monocytes and
macrophages (M-tropic) [3]. These receptors promote
viral attachment and fusion to cellular membranes, thus
facilitating entry into hematopoietic cells [4]. Although
the peripheral blood-derived hematopoietic progenitor
cells (HPCs) can express the HIV-1 co-receptors [5],
susceptibility to either T-tropic or M-tropic strains of
HIV-1 seem to correlate only with lineage commitment
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CD34
+ HPCs and impaired clonogenic potential and
apoptosis of these progenitor cells have been documen-
ted in HIV-1 infected individuals [7,8], the evidence of
productive infection of HPCs remains controversial
[9,10].
The mesenchymal stem cells (MSCs) are endowed
with multi lineage differentiation potentials and self-
renewal properties, which qualify them as potential
sources for cell transplantation and gene therapy. MSCs
from several origins, including bone marrow and adi-
pose tissue, have been well described. Adipose tissue
derived MSCs (ASCs), like bone marrow derived MSCs,
have the capacity to differentiate along multiple lineages
at clonal levels. They can differentiate into neurons, car-
diomyocytes, chondrocytes, osteocytes, and adipocytes
[11-16]. However, it is not known whether lineage speci-
fic differentiation of MSCs would enable them to be
infected by HIV-1 and whether they may act as long-
term viral reservoirs within systemic sites.
The HIV-1 infection of bone marrow mesenchymal
progenitors and of mesenchyme-derived cells (e.g., fibro-
blasts and endothelial cells) present in various peripheral
organs has been shown to occur via both M-tropic and
T-tropic strains of HIV-1 [17-19]; however, integrated
provirus is rarely found in these cells and a productive
infection has not been documented. However, in vitro
infection of stromal cells grown in long-term bone mar-
row cultures (LTBMC) with HIV-1 has been reported
[20-22]. Our previous studies had shown that a T-tropic
strain of HIV-1 can infect bone marrow MSC cultures
and decrease their colony forming ability and adipogenic
potential [23]. Further, it has also been shown that mul-
tipotent human progenitor cells isolated from fetal
brains are permissive towards HIV-1 infection [24].
However, it has not been well established as to how
these mesenchyme derived cells become susceptible to
HIV-1 and whether their HIV-1 production rates are
comparable to that observed in HIV-1 infected lym-
phoid or myeloid cells. Importantly, despite the possible
presence of ASCs in systemic organs, there is no evi-
dence about the ability of HIV-1 to infect either undif-
ferentiated ASCs or their differentiated counterparts.
Recent work from our laboratory has demonstrated
that under specific in vitro stimulations even the CD34
-
ASC clones (CD90
+, CD105
+,C D 4 5
- and CD34
-)c o u l d
undergo hematopoietic differentiation (HD) and display
macrophage-like characteristics [25]. Macrophages are
known to play a crucial role in both HIV-1 infectivity
and pathogenesis. Although they can generate high
levels of viral progeny, they are resistant to HIV-1
induced cytopathic effects and harbor the virus for
a long time [26-28]. Hence, our efforts were focused
on studying the susceptibility of the ASCs and the
HD-differentiated ASCs for HIV-1 infection and their
subsequent abilities to support viral replication. Initially,
the differentiated cells were analyzed for receptors,
ligand binding, and cofactors, which are directly
involved in HIV-1 infection, followed by analysis of
changes in gene expression that occurs following HIV-1
infection. Both HIV-1 susceptibility markers and pro-
ductive replication in HIV-1 exposed HD cells were
compared with those observed in a HIV-1 infected T-
cell line, and the findings are reported in the present
study.
Results
Up-regulation of HIV-1 susceptibility genes in HD cells
HD cells were prepared by differentiating expanded cul-
tures of ASC clones, phenotypically identified as CD90
+,
CD105
+,C D 4 4
+,C D 4
-,C D 6 8
-,C D 3 4
-,C D 4 5
-,a n d
CD11b
- cells as described previously [25]. For the initial
assessment of HD cells, we performed a transcriptomic
analysis after 8 days of differentiation. The HD cells
expressed a number of HIV-1 receptors such CD4 (33.9 ±
3.4 fold), CXCR4 (2.7 ± 0.42 fold), CCR4 (1.64 ± 0.05 fold),
and CCR5 (1.93 ± 0.26 fold) compared to undifferentiated
ASCs (Figure 1A). HD cells also expressed a series of
genes involved in innate and adaptive immune reactions
and key cellular cofactors for HIV-1 infection such as IL-8,
SERPINA1, CCL8, CD69 and interleukins 2, 10, and 16
(Figure 1B). The expression of lymphoid associated gene
BCL11B was markedly up regulated. Further, the expres-
sion of a number of cell cycle regulators, such as BAX,
CDKN1A, FOS, GADD45A, NFATC1, CEBPB, STAT1,
and STAT3, decreased while the expression of NFB1A
slightly increased as a result of differentiation (Figure 1C).
A highly productive HIV-1 infection is evident in virus
exposed HD cells
Since cells of the hematopoietic system are among the
main targets of the HIV-1 virus, we investigated the
effect of viral exposure on HD cells. Clonally expanded
cells were allowed to differentiate into HD cells for 5 (5-
HD) or 8 (8-HD) days in differentiation media. For ana-
lyzing the infectivity of HD cells, we exposed them to
very low levels of HIV-1 virus (10
3-10
4 TU/10
5 cells or
0.1 MOI) for 24 hours. Unbound viral particles were
removed and cultures maintained for an additional 5
days. Following infection of HD cells, noticeable mor-
phological changes beginning from day 3 post-infection
were observed. These morphological changes heralded a
loss of significant numbers of cells by day 5 post-infec-
tion, indicating the dominance of viral infection on HD
cells (Figure 2). Subsequently using ELISA for HIV-1
p24, we assayed the levels of HIV-1 p24 released in the
supernatant of HD-HIV, and HIV-1 exposed undifferen-
tiated ASCs (ASCs-HIV) cultures which served as
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Figure 1 Gene expression analysis of HD cells following hematopoietic differentiation. Compared to ASCs, the expression level of HIV
receptor genes (CD4, CXCR4, CCR4, and CCR5) were up regulated in HD cells as result of differentiation (A). Expression of several genes involved
in innate and adaptive immune reactions (B), and cell cycle regulators (C) were altered in HD cells. A fold change was applied to select genes
(P < 0.05). All values are normalized to ASCs (X axis).
Day0 Day3 Day5
Figure 2 Morphological changes in differentiated HD cells following exposure to HIV-1.D a y - 0 ,H Dc e l l sw h i c ha r eo nd a y8
th
of differentiation and before viral infection. Day-3, shows the morphological changes of HD cells following 72 hours of viral infection. Day-5,
morphology of HD cells infected with HIV-1 virus following 120 hours of infection. Images were taken with Nikon Eclipse 2000. Scale bar is
100 μm.
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tant is depicted in Figure 3A.
Both 5-HD and 8-HD cultures showed consecutively
increasing levels of p24 on days 3 to 5. On day 5 of
infection, p24 levels in 5-HD and 8-HD cultures
remained unchanged; the p24 levels in ASCs-HIV were
negligible, indicating no evidence of viral replication.
To quantify HIV-1 cDNA and proviral DNA, the
mRNA level of “gag” and “Tat” were assayed. Figure 3B
shows the increased expression of gag in HD-HIV cells
3 days post infection. This level decreased significantly
by day 5 after infection. The gag expression in HD-HIV
cells was comparable to the HIV-1 infected “HUT-78”
(HUT78-HIV), a T-lymphoblastoid cell line that served
a sap o s i t i v ec o n t r o li nt h e s ee x p e r i m e n t s .T h eR T - P C R
experiments showed enhanced expression of Tat in HD-
HIV and HUT78-HIV cells (Figure 3C). The expression
of gag and Tat were not detected in ASCs-HIV.
HIV-1 infection significantly alters the gene expression
profile in HD cells
The expression of selected genes mainly involved in
HIV-1 infection and immune response was analyzed as
described in the methods. The results obtained for
each group, normalized to the mean value of the house
keeping gene, were compared by scatter plot analysis
using PCR-array data analysis software (SABios-
ciences). To study the effect of viral exposure on HD
cells, we compared the expression of selected genes in
HD-HIV cells versus un-infected HD cells. The gene
profile of HD-HIV cells was then compared to
HUT78-HIV cells. The analysis showed that HIV-1
infection altered gene expression within HD cells in a
similar fashion to that seen in HUT78-HIV cells. Sev-
eral genes were perturbed in response to viral expo-
sure, and these included genes coding for HIV-1
receptors and ligands (CCL4, CCL5, CCR5, CXCL12,
CXCR4, CXCL12). The viral exposure showed its maxi-
mum effect on the HD-HIV cells, when compared to
HUT78-HIV cells (Figure 4A).
HIV-1 infection also profoundly altered expression of
the cell cycle and apoptosis regulatory genes including
BAX, BCL2, CDKN1A, GADD45A, CDk9, IRF1, CEBPB,
and IRF2. The changes in the expression levels of these
genes were more pronounced in HD-HIV cells when
compared to HUT78-HIV. However, there were smaller
A B
C
Figure 3 Expression of HIV-1 p24 protein in HD-HIV and ASC-HIV cells. p24 antigen level was monitored following post exposure to HIV-1
for 24 hr. HIV-1 was exposed to undifferentiated, 5-HD and 8-HD cells and p24 level was measured after 1, 3 and 5 days following removal of
virus (A). Data represent the compilation of three separate experiments carried out in triplicates (P < 0.0001). (B) HIV-1 gag expression in HD-HIV
and HUT78-HIV cells and compared to HIV-1 exposed ASCs (P < 0.05). (C) mRNA was extracted from ASC-HIV, HD-HIV, and HUT78-HIV cells and
RT-PCR was performed for Tat expression.
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Figure 4 Comparison of the gene expression profiles of HIV-1 infected HD and HUT78 cells. Genes that were found to be differentially
expressed in HD-HIV vs. HD cells in one set and HD-HIV vs. HUT78-HIV cells in another set were then grouped according to functional
categories including genes encoding for HIV-1 receptors and ligands (A), cell cycle and apopotosis (B), and cellular factors involved in HIV-1
infection (C). A fold change was applied to select genes (P < 0.05). All values are normalized to either ASCs or HD cells (X axis).
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NFBIA, TNSF10, STAT1, and STAT3 (Figure 4B).
HIV-1 infection caused significant changes in the
expression of cellular factors involved in HIV-1 infection
such as BANF1, CD247, TRIM5, VPS4A, XPO1, CD209
and to a lesser extent, changed the expression levels of a
b-transducin repeat containing (BTRC), CBX5,a n d
HTATSF1. HD cells showed enhanced expression of
genes coding for factors known to restrict HIV-1 repli-
cation such as CD209, APOBEC3F, Tat specific factor 1
(TAT-SF1), and tripartite motif-containing 5 (TRIM5)
(Figure 4C).
Immunocytochemistry was employed to analyze the
expression of CCR4, CCR5, NOS2 and CXCR4 proteins
in HD-HIV cells. As shown in Figure 5, these markers
could be readily detected in approximately all cells.
However, the expression of CD4 was in undetectable
levels by immunohistochemistry
Productive infection is not seen in undifferentiated ASCs
Undifferentiated ASCs exposed to HIV-1 resulted in no
significant productive infection up to 5 days. In addition,
viral exposure did not cause noticeable effects on the
viability of ASCs. Exposure to low MOI (0.1) of the
virus did not show any significant effect on the expres-
sion of CD4, CD14, CD68, MSR1, TNFa and MRC1 in
ASCs. However, exposure to HIV-1 resulted in a provi-
sional up-regulation of c-Kit (6.4 ± 1.4 fold, p ≤ 0.05),
IL10 (188.9 ± 1.6 fold, p ≤ 0.01) and MMD2 (65 ± 1.1
fold, p ≤ 0.01) by day 3 post-exposure. By day 5, the
expression of these genes decreased, however, the levels
w e r es t i l lh i g h e rt h a ni nt h eu n - e x p o s e dc o n t r o lA S C s
(IL10 = 67.5 ± 1.5, p ≤ 0.01; MMD2 = 24.3 ± 1.3, p ≤
0.01; and c-Kit =4 . 1±1 . 9 ,p≥ 0.05). The decline in the
expression of MMD2 on day 5 as compared to day 3
was significant (p ≤ 0.01) (Figure 6). Our observations
indicate that the HIV-1 exposed ASCs showed signifi-
cantly lower adipogenic, osteogenic potential. However,
HIV exposure seems to expedite the generation of HD
cells to less than 5 days (from the normal 8 days), when
placed in hematopoietic differentiation media. The gen-
erated HD cells from HIV-1 exposed ASCs did not exhi-
bit any evidence of productive infection.
The possible integration of HIV-1 in an exposed ASC
genome was examined by repetitive-sampling Alu-gag PCR
technique described earlier [29]. Briefly, on a nested based
PCR technique, the regions of varying length between
genomic Alu repeats and the HIV gag were amplified from
the DNA of exposed ASCs to 0.1 MOI of HIV-1 for 24 h.
Following this, the second PCR was performed on specific
regions of the HIV-1 genome. No evidence of HIV-1 inte-
gration was observed in exposed ASCs.
Discussion
In postnatal and adult life, macrophages differentiate
from progenitor cells through various pathways. Macro-
phages are known to be one of the most important tar-
gets for HIV-1 infection and play a crucial role in both
viral latency and recrudescence. The CD34
+ hemato-
poietic progenitor cells are commonly known to gener-
ate macrophages. Furthermore, the ability of embryonic
stem cells to generate HIV-1 susceptible macrophages
has been reported [30]. For the first time we showed
that a clonally expanded CD90
+, CD105
+,C D 4 4
+,C D 4
-,
CD34
-,C D 4 5
-,C D 1 1 b
-,C D 6 8
- subset of ASCs could
also generate cells with macrophage attributes [25]. In
the present study, we show that the generated HD cells
support productive HIV-1i n f e c t i o n .W es h o wt h e
expression of several HIV-1 susceptibility genes as well
as several immune response genes in HD cells. A num-
ber of such newly expressed genes may possibly be
involved in increasing the susceptibility of HD cells to
HIV-1 infection.
Previously we showed that early in differentiation, HD
cells develop CD4, a T-lymphocyte marker [25]. Since
we utilized the HTLV-IIIB strain which is a T-tropic
virus, the infectivity in HD cells as compared to the
newly infected HUT78 cells can be explained by utiliz-
ing CD4 as one of the most important HIV-1 receptors.
Furthermore, as a result of differentiation, expression
of other common cellular ligands essential for HIV-1
infection, such as CXCR4, CCR4,a n dCCR5, distinctly
increased. In addition, the expression of markers asso-
ciated with activated immune cells, such as the serine
protease inhibitor SERPIN-A1; the cell surface markers
such as CCL8, CD69;a sw e l la st h ee x p r e s s i o no fi n t e r -
leukins such as IL-2, IL-8, IL-10,a n dIL-16, were mark-
edly increased in the HD cells. These observations
clearly indicated that these mesenchymal origin cells
acquired the attributes of hematopoietic cells.
Our current findings clearly demonstrate a profound
increase in the susceptibility of HD cells to HIV-1 infec-
tion. Interestingly, higher levels of p24 expression were
o b s e r v e di n8 - H Dc o m p a r e dt o5 - H Dc e l l s .T h i si ss u g -
gestive that 8-HD cells develop even more cellular
receptors for viral entry and are prone for replication.
The negligible amount of p24 in ASCs-HIV might be
associated with a residual amount of virus floating in
the media. Compared to HUT78 cells, the HD cells sup-
ported a highly productive HIV-1 infection as evident
from the significantly higher levels of gag and Tat
expression in both cell types post HIV-1 exposure. The
gag expression level decreased in HD-HIV on day-5
post infection which was due to considerable cytotoxi-
city associated with the HIV infection (Figure 3B).
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exposed them to very low levels of the virus (0.1 MOI).
Indeed, similar to the high level of infectivity observed
in the HUT78 cells, the HD cells showed increasing
levels of p24 in the supernatants on both day-3 and
day-5 post infection, suggesting a possible and crucial
role in vivo in providing infectable cells.
Interestingly, HIV-1 exposed cells showed a significant
decrease in expression of CD4. Significant increases in
the expression of HIV-1 co-receptors, both CCR5, and
CXCR4 were observed in the HD-HIV cells in both
gene and protein levels. Although we have not carried
out studies using an M-tropic virus, our findings point
towards virus infection that enables HD cells to be sus-
ceptible to both of R5 and X4 viruses. Previous reports
determined that the HIV-1 Tat protein alters co-recep-
tor expression in lymphoid and myeloid cells [31,32].
Studies from our laboratory on the HPC cell line, K562
CCR5
CCR4
NOS2
CXCR4
Figure 5 Expression of hematopoietic markers in HD cells following HIV infection. Immunohistochemistry of HD-HIV cells, fluorescent
images indicate the expression of CCR5, CCR4, NOS2, and CXCR4. Right panel shows the DIC images of identical fields. Images were obtained
with Leica TCS SP-2 confocal microscope. Scale bar 10 μm.
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both CXCR4 and CCR5 expression in erythroid or
megakaryocytic cells [33].A l t h o u g hw eh a v en o tm e a -
sured Tat expression in the HD-HIV cells, the level of
productive infection clearly suggests high levels of Tat
protein which may be directly involved in changes in
HIV-1 receptor expression observed in these cells.
As compared to the newly infected HUT78-HIV cells,
the HD-HIV cells showed significantly higher level of
expression of several chemokines such as CXCL12,
CCL4 and CCL5.C C L 4( M I P - 1 b)i sam a j o rH I V - s u p -
pressive factor produced by CD8
+ T cells [34]. It has
also been documented that MIP-1a and RANTES, as
ligands for CCR5, may suppress HIV-1 infection as well
[ 3 5 ] .A ni n c r e a s ei nC X C L 1 2( S D F - 1 a) in lymphocytes
has also been associated with decreased infectivity of
HPCs via the X4-tropic strains of HIV-1 [32]. In HD-
HIV cells, the increased expression of several chemo-
kines may thus suggest that the cells are combating to
inhibit virus infection by producing these ligands which
compete for HIV-1 binding to cells. In addition, this
may also suggest that by secreting these chemokines the
HD-HIV cells may enhance the recruitment of virus
infectable cells to the microenvironments in vivo.
Although we have not measured the levels of these che-
mokines produced from the HD-HIV cells, an increase
in their gene expressions of almost over 10 fold indi-
cates their protein levels may also be augmented and
m a yt h e r e f o r ep l a yac r u c i a lr o l ei nt h ed e v e l o p m e n to f
HIV-1 reservoirs.
Although the levels of productive infection (both p24
protein, gag and Tat mRNA levels) were almost similar
in the HD-HIV and HUT78-HIV cells, there were sev-
eral other salient differences in the gene expression pro-
files following HIV-1 infection. In addition to the
differences in chemokine and their receptor expressions
(Figure 4A), significant differences were seen in several
apoptotic markers (Figure 4B) and in several lineage
specific transcription factors (Figure 4C). In the HD
cells, HIV-1 infection altered the expression of genes
associated with apoptosis such as BAX, BCL2, CASP3
and GADD45a. HD cells also exhibited elevated levels
of BCL11B, a transcription factor expressed in T-cells
[36]. Interestingly, BCL11B has been found to repress
HIV-1 transcription from the 5’ long terminal repeat
[37]. Genes associated with cell cycle regulation, such as
CDKN1A, CDK7 and most importantly CDK9, were also
up regulated in the HD-HIV cells, as compared to unin-
fected HD as well as HUT78-HIV cells. Since, CDK9
plays a crucial role in HIV-1 Tat protein mediated
transactivation, a possible role of increased Tat function
in the productive infection may also be considered
likely. Indeed, the expression of several other transcrip-
tion factors that are also known to regulate HIV-1 pro-
moter activity, e.g. CEBP-b and both STAT1 and STAT3
genes, were also up regulated in HD-HIV cells, as com-
pared to uninfected HD as well as HUT78-HIV cells.
Interestingly, the mRNA expression of NFB1A, the p65
subunit of the transcription factor NFB which also reg-
ulates HIV-1 gene expression in stimulated lymphocytes,
was not decisively altered in these cells. However, sev-
eral cell surface receptors that regulate intracellular
NFB activity, such as TNFSF10 and both IRF1 and
IRF2 were higher.
The up-regulation of Bax, which results in a loss of
mitochondrial membrane polarization and release of
pro-apoptotic factors culminating in caspase activation
and apoptosis, has been documented [38]. Andersen and
coworkers have reported that the expression of
GADD45A was increased following stressful growth
arrest conditions as a result of HIV-1 infection [39].
HIV-1 has also been shown to regulate the expression
of CDK9 [40]. It has been shown that STAT3 promotes
the initiation of transcription and regulates chromatin
remodeling and transcription elongation through its
interaction with CDK9 [41].
We also found that the expression of several genes
such as BANF1, BTRC, CD209, APOBEC3F,a n dTAT-
SF1 increased in HD-HIV cells. BANF1 is known for
its ability to protect retroviruses from intra-molecular
integration and there by promoting intermolecular
integration into the host cell genome [42]. BTRC
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Figure 6 Effects of HIV-1 exposure on gene expression of ASCs.
The gene expression levels were calculated based on the dCT-
values which have been standardized with the GADPH levels. The
ASCs (n = 4 donors) were harvested following 3 and 5 days after
exposure to HIV-1. IL10, c-Kit, and MMD2 expression increased
significantly by 3 days post HIV-1 exposure (P < 0.05, * represents
P < 0.01). The ASCs showed no morphological changes during the
course of experiment.
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nects CD4 to the proteolytic machinery [43]. CD209
expression has been reported in association with
HIV-1 infection [44]. APOBEC3F potently restrict
HIV-1 replication, and is neutralized by the viral
protein Vif [45]. Increased TAT-SF1 expression in
HD-HIV cells was significant and since it has been
shown that TAT-SF1 is required for maintaining the
ratios of different classes of HIV-1 transcripts [46].
These findings suggest that pathways that facilitate
productive infection in T-cells may also be induced in
the HD-HIV cells, as is clearly evident from the levels
of p24 and gag and Tat expression in both cell types.
In the present studies for the first time, the infective
property of HIV-1 on cells derived from ASCs is
reported. It has been reported that HIV-1 stimulates
the secretion of the adipocyte-derived hormone adipo-
nectin, however no evidence of infectivity of the virus
on adipocytes were shown [47]. Our studies show that
ASCs respond to HIV-1 exposure by increasing expres-
sion of IL-10, c-Kit,a n dMMD2. Although these effects
do not ultimately result in productive infection, data
revealed that HIV-1 exposure increases the hemato-
poietic lineage commitment of ASCs. The enhanced
hematopoietic capacity of HIV-1 exposed ASCs was
concurrent with decline in their adipogenic and osteo-
genic potential. Recently, it has been reported that
chronic exposure of CD4
+,C X C R 4
+,a n dC C R 5
+
mesenchymal stem cells with high viral load sera
enhanced the adipogenesis [48]. While the treatment of
cells with low viral load did not alter differentiation
potential of those cells, the ASC clones used in this
study were negative for CD4, CXCR4,a n dCCR5.I n
addition, our data suggest no HIV-1 integration into
the ASC genome. These results of the present study
shed light on the effect of HIV-1 on tissue resident
stem cells paving way for additional studies to explore
the mechanistic insights for understanding and man-
agement of the disease process.
Conclusion
Based on the observations reported, it is now feasible to
study the effect of anti-HIV treatments on ASC derived
HD cells. The presence of phenomenal numbers of
ASCs in adipose tissue, and these novel findings which
indicate that HIV-1 exposure may facilitate their macro-
phage type commitment, demonstrates that these cells
may have importance in generating systemic viral reser-
voirs. Further, the utility of ASC as well as the ASC
derived HD cells as a possible tool for future gene ther-
apy against HIV-1 seems to be promising and merits
additional investigation.
Methods
Cell culture and Hematopoietic Differentiation
All human tissue sample collection protocols were
reviewed and approved by Institutional Review Board
(IRB) of Tulane University. Human ASCs were isolated
from adipose tissue of healthy donors (n = 14) based on
the methods described earlier [49]. ASCs clones were
isolated and expanded in a-MEM (CellGro, Manassas,
VA) based media, supplemented with 20% fetal bovine
serum (Atlanta Biologicals, Lawrenceville, GA), 1%
L-Glutamine (CellGro, Manassas, VA) and 1% penicil-
lin/streptomycin (CellGro, Manassas, VA) at 37°C in 5%
CO2. Then clones were cultured in differentiation media
according to a previously described method [25]. Briefly,
clonally expanded ASCs were plated at a density of 5000
cells/cm
2 on either cell culture dishes or chamber slides
(Nalgene, Nunc, Rochester, NY). The differentiation
media consisted of a-MEM, 10% FBS, 0.1 μl/ml
1-monothioglycerol (MTG) (Sigma-Aldrich Inc. St. Louis,
MO), supplemented with 100 U/ml IL-1ß, 500 U/ml IL-
3, and 20 U/ml M-CSF (Prospec Bio, Rehovot, Isreal) as
stimulating substances. 30% of the primary volume was
augmented with fresh media every 2 days for 12 days.
Cultures of ASC clones in growth media containing 10%
FBS served as control undifferentiated cells.
HIV-1 Infection
The uninfected T4-lymphocyte line HUT78, and HUT78
cells persistently infected with HTLV-IIIB strain of HIV-
1 (from the AIDS Research & Reference Reagent Pro-
gram, Bethesda, MD) were cultured in RPMI medium,
supplemented with 10% FBS and antibiotics (penicillin
& streptomycin). Cell-free viral stocks were obtained
from the supernatants of HTLV-IIIB infected cell line
grown to 50-60% confluency. The viral titers were deter-
mined by measuring HIV-1 p24 levels using an ELISA
kit as per the manufacturer’s protocol (ZeptoMetrix,
Buffalo, NY). For ASC infection studies, cells were cul-
tured in differentiation media for either 5 (5-HD) or 8
(8-HD) days, and subsequently exposed to cell free virus
for 24 hr. For HUT-78 cell infection, uninfected cells
growing in the logarithmic phase were exposed to cell
free virus for 24 hrs. All HIV-1 exposure studies were
performed using a viral stock of ~100 pg/ml of p24
[10
3-10
4 transducing units (TU)/ml]. Each viral stock
was freshly prepared before exposure of ASCs or unin-
fected HUT78 cells. For controls, un-differentiated
ASCs and HUT78 cells were exposed to the same num-
ber of viral particles. Following 24 hrs of virus exposure,
cells were washed several times using fresh media to
remove the unattached viral particles and cultured for 3
or 5 days post exposure. Prior to viral infection, ASCs
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days, and subsequently exposed to HIV-1 in cell free
viral media. Viral p24 levels were analyzed at each time
point to monitor the viral replication in un-differen-
tiated, HD, and HUT78 cells. A graphical representa-
tion of p24 level (pg/ml) vs time point (days) was
carried out. Values with p < 0.0001 were considered
significant.
Alu-gag PCR
The genomic DNA from exposed HIV-1 ASCs was sub-
jected to two step Alu-gag PCR technique described by
Liszewski et al. [29]. In the first step the Alu-gag regions
were amplified using following primers: 1. Alu (For-
ward): 5’ GCC TCC CAA AGT GCT GGG ATT ACA
G-3’;H I Vgag (Reverse): nucleotides (nt) 1505-1486 5’
GTT CCT GCT ATG TCA CTT CC-3’.O nt h es e c o n d
step, RU5 region in gag was detected using the following
primers: RU5 (R Forward): nt 518-539 5’-TTA AGC
CTC AAT AAA GCT TGC C-3’; RU5 (U5 Reverse): nt
647-628 5’-GTT CGG GCG CCA CTG CTA GA-3’;5 .
RU5wildtype Probe: nt 584-559 5’-CCA GAG TCA
CAC AAC AGA CGG GCA CA-3’;R U 5 d e g e n e r a t e 1
Probe: nt 584-559 5’-CCA GAG TCA CAT AAC AGA
CGG GCA CA-3’; and RU5degenerate2 Probe: nt 584-
559 5’-CCA GAG TCA CAC AAC AGA TGG GCA
CA-3’.T h eP C Rp r o d u c t sw e r ea nalyzed by agarose gel
electrophoresis.
RT
2 qPCR gene expression analysis
Using total cellular RNA the gene expression was car-
ried out on PCR array kits (SABiosciences, Frederick,
MD) which profiles the expression of 84 genes involved
in susceptibility to HIV-1, infection and related immune
response. The cellular RNAs from un-differentiated
ASCs, HD, and HIV-1 infected HD cells (HD-HIV) (n =
3d o n o r s )w i t hH I V - 1i n f e c t e dH U T 7 8( H U T 7 8 - H I V )
(serving as positive controls) were used. Data were ana-
lyzed using software provided by SABiosciences http://
www.sabiosciences.com. Differential gene expression was
evaluated for statistical significance (p < 0.05). A cut off
of 2 for fold change for up-regulated and 0.5 for down
regulated genes was applied, so as to only consider
genes whose expression was perturbed in magnitude as
well as in a significant manner.
RT-PCR and Real-Time RT-PCR
Real-Time RT-PCR was performed using SYBR Green
Master mix (Invitrogen, Carlsbad, CA) in a 2-step proto-
col (50 cycles of 10 sec at 90°C and 45 sec at Tm). The
following primers were used to assess the gene expres-
sions. CD4:5 ’-GTA GTA GCC CCT CAG TGC AA-3’,
5’-AAA GCT AGC ACC ACG ATG TC-3’; CD14:5 ’-
ACA GGA CTT GCA CTT TCC AG-3’,5 ’-TCC AGG
ATT GTC AGA CAG GT-3’; CD68:5 ’-CAA CTG CCA
CTC ACA GTC CT-3’,5 ’-CAA TGG TCT CCT TGG
AGG TT-3’; IL10:5 ’-AAG CCT GAC CAC GCT TTC
TA-3’,5 ’-ATG AAG TGG TTG GGG AAT GA-3’;
ITGAM:5 ’-ACG GAT GGA GAA AAG TTT GG-3’,5 ’-
CAA AGA TCT TCT CCC GAA GC-3’; c-KIT:5 ’-CCG
TGG TAG ACC ATT CTG TG-3’,5 ’-GTG CCC ACT
ATC CTG GAG TT-3’; MMD2:5 ’-GCA GAC CAA
GGT GTC CAA AT-3’,5 ’-CTG GCT GTC ACC AGA
AGT CA-3’; MRC1:5 ’-GGC GGT GAC CTC ACA
AGT AT-3’,5 ’-ACG AAG CCA TTT GGT AAA CG-3’;
MSR1:5 ’- T C CT C GT G TT T GC A GT T CT C - 3 ’,5 ’-
CAT GTT GCT CAT GTG TTC CA-3’; TNF:5 ’-TCC
TTC AGA CAC CCT CAA CC-3’,5 ’-AGG CCC CAG
TTT GAA TTC TT-3’; gag:5 ’-ATA ATC CAC CTA
TCC CAG TAG GAG AAA T-3’,5 ’-TTT GGT CCT
TGT CTT ATG TCC AGA ATG C-3’; Tat: 5’-GGA
A T TC A CC A TG G AG C CA G TA G AT C CT - 3 ’,5 ’-
CGG GAT CCC TAT TCC TTC GGG CCT GT-3’;
GAPDH 5’-CGA GAT CCC TCCA AAA TCA A-3’ and
5’-GGT GCT AAG CAG TTG GTG GT-3’.T h ed a t a
were generated using an iCycler MyiQ (Biorad) and ana-
lyzed using the iQ5 V2.0 (Bio-Rad). The RT-PCR pro-
ducts were analyzed using agarose gel electrophoresis
(1% agarose gel) and stained in 10 μg/ml ethidium bro-
mid (Sigma) for visualization. For real-time RT-PCR, the
equation 2
-ΔΔCT was used for calculating fold changes.
A threshold cycle of 35 was chosen as the cut-off for
non-detectable genes, thus genes with CT values above
35 were considered not expressed.
Immunocytochemistry
HD cells were prepared and infected with HIV, the
fixed, permeabilized, and incubated with human specific
primary antibodies for CCR4, CCR5, CXCR4, and NOS2
at a final concentration of 0.02-0.04 mg/ml, then incu-
bated with 0.002 mg/ml of the matching secondary anti-
body. The signal was detected with a Leica TCS SP-2
confocal microscope equipped with Argon (457-477 nm;
488 nm, 514 nm) and HeNe lasers (543 nm; 633 nm) at
a magnification of HCX PL APO 63×/1.4 at 21°C. Data
were processed with Leica confocal software.
Osteogenic and Adipogenic Differentiation
Adipogenic differentiation was determined in cultures of
ASCs following HIV exposure using previously
described methods [16]. Adipogenic potentials were
evaluated by oil red O staining. Osteogenic differentia-
tion was induced as previously described [50]. Differen-
tiated cells were either fixed and stained with Alizarin
Red (Diagnostic BioSystems) or quantified for alkaline
phosphatase activity (ALP) using the SensoLyte™ pNPP
Alkaline Phosphatase Assay Kit (AnaSpec, San Jose,
CA). All analyzes were carried out in triplicates.
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Page 10 of 12Statistical analysis
All data relating to this study were summarized using
descriptive statistics such as mean, standard deviation
and standard error. The analysis of variance method was
used to compare the mean differences. Where meaning-
ful, the results were presented graphically. The study
hypotheses were tested at 5% level of significance
throughout the analysis. Estimates of means and their
95% confidence intervals were calculated. R-computing
software was used to plot the graphs.
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